Funds Holding Immunomedics, Inc.

 
Stock Quotes for Immunomedics, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Slow Growth
Sign-up for immu investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Slow Growth
Sign-up for immu investment picks

 
News Articles for Immunomedics, Inc. top ^
2014/12/3
MORRIS PLAINS, N.J., Dec.
Sign-up for Immunomedics Announces Outcome of 2014 Annual Meeting of Stockholders investment picks
2014/12/4
MORRIS PLAINS, N.J., Dec.
Sign-up for Immunomedics to Present at 25th Annual Oppenheimer Healthcare Conference investment picks
2015/1/6
MORRIS PLAINS, N.J., Jan.
Sign-up for Immunomedics Appoints Dr. Francois Wilhelm Chief Medical Officer investment picks
2015/1/5
MORRIS PLAINS, N.J., Jan.
Sign-up for Immunomedics Awarded Fast Track Designation by FDA for Sacituzumab Govitecan (IMMU-132) for Triple-Negative Breast Cancer Therapy investment picks
2014/12/15
SAN ANTONIO, Dec.
Sign-up for Immunomedics Reports Preliminary Results From Pretargeted Imaging Study in Patients With Metastatic Breast Cancer investment picks
2015/1/29
MORRIS PLAINS, N.J., Jan.
Sign-up for Immunomedics Announces Dismissal of Putative Class Action Lawsuit investment picks
2015/2/5
MORRIS PLAINS, N.J., Feb.
Sign-up for Immunomedics Announces Pricing of Offering of $85 Million of 4.75% Convertible Senior Notes Due 2020 investment picks
2015/2/4
MORRIS PLAINS, N.J., Feb.
Sign-up for Immunomedics Announces Proposed Offering of $85 Million of Convertible Senior Notes Due 2020 investment picks
2015/2/4
MORRIS PLAINS, N.J., Feb.
Sign-up for Immunomedics Announces Second Quarter Fiscal 2015 Results and Clinical Program Developments investment picks
2015/2/3
MORRIS PLAINS, N.J., Feb.
Sign-up for Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2015 Financial Results investment picks
2015/2/19
SANTA MONICA, Calif., Feb.
Sign-up for Immunomedics Presents Updated Results With Sacituzumab Govitecan in Lung Cancer investment picks
2015/2/12
MORRIS PLAINS, N.J., Feb.
Sign-up for Immunomedics Announces Completion of Offering of $85 Million of 4.75% Convertible Senior Notes Due 2020 investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Funds Holding Immunomedics, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Immunogen, Inc.  |  Next: Funds Holding Impala Platinum Holdings